RESUMEN
OBJECTIVES: Articular cartilage is vulnerable to injuries and undergoes an irreversible degenerative process. The use of amniotic fluid mesenchymal stromal stem cells for the reconstruction of articular cartilage is a promising therapeutic alternative. The aim of this study was to investigate the chondrogenic potential of amniotic fluid mesenchymal stromal stem cells from human amniotic fluid from second trimester pregnant women in a micromass system (high-density cell culture) with TGF-ß3 for 21 days. METHODS: Micromass was performed using amniotic fluid mesenchymal stromal stem cells previously cultured in a monolayer. Chondrocytes from adult human normal cartilage were used as controls. After 21 days, chondrogenic potential was determined by measuring the expression of genes, such as SOX-9, type II collagen and aggrecan, in newly differentiated cells by real-time PCR (qRT-PCR). The production of type II collagen protein was observed by western blotting. Immunohistochemistry analysis was also performed to detect collagen type II and aggrecan. This study was approved by the local ethics committee. RESULTS: SOX-9, aggrecan and type II collagen were expressed in newly differentiated chondrocytes. The expression of SOX-9 was significantly higher in newly differentiated chondrocytes than in adult cartilage. Collagen type II protein was also detected. CONCLUSION: We demonstrate that stem cells from human amniotic fluid are a suitable source for chondrogenesis when cultured in a micromass system. amniotic fluid mesenchymal stromal stem cells are an extremely viable source for clinical applications, and our results suggest the possibility of using human amniotic fluid as a source of mesenchymal stem cells.
Asunto(s)
Técnicas de Cultivo de Célula/métodos , Condrocitos/citología , Condrogénesis , Células Madre Mesenquimatosas/citología , Agrecanos/metabolismo , Líquido Amniótico , Diferenciación Celular , Colágeno Tipo II/análisis , Femenino , Expresión Génica , Humanos , Embarazo , Factor de Transcripción SOX9/metabolismo , Factor de Crecimiento Transformador beta3/metabolismoRESUMEN
OBJECTIVES: Articular cartilage is vulnerable to injuries and undergoes an irreversible degenerative process. The use of amniotic fluid mesenchymal stromal stem cells for the reconstruction of articular cartilage is a promising therapeutic alternative. The aim of this study was to investigate the chondrogenic potential of amniotic fluid mesenchymal stromal stem cells from human amniotic fluid from second trimester pregnant women in a micromass system (high-density cell culture) with TGF-β3 for 21 days. METHODS: Micromass was performed using amniotic fluid mesenchymal stromal stem cells previously cultured in a monolayer. Chondrocytes from adult human normal cartilage were used as controls. After 21 days, chondrogenic potential was determined by measuring the expression of genes, such as SOX-9, type II collagen and aggrecan, in newly differentiated cells by real-time PCR (qRT-PCR). The production of type II collagen protein was observed by western blotting. Immunohistochemistry analysis was also performed to detect collagen type II and aggrecan. This study was approved by the local ethics committee. RESULTS: SOX-9, aggrecan and type II collagen were expressed in newly differentiated chondrocytes. The expression of SOX-9 was significantly higher in newly differentiated chondrocytes than in adult cartilage. Collagen type II protein was also detected. CONCLUSION: We demonstrate that stem cells from human amniotic fluid are a suitable source for chondrogenesis when cultured in a micromass system. amniotic fluid mesenchymal stromal stem cells are an extremely viable source for clinical applications, and our results suggest the possibility of using human amniotic fluid as a source of mesenchymal stem cells.
Asunto(s)
Humanos , Embarazo , Técnicas de Cultivo de Célula/métodos , Condrocitos/citología , Condrogénesis , Células Madre Mesenquimatosas/citología , Expresión Génica , Diferenciación Celular , Colágeno Tipo II/análisis , Agrecanos/metabolismo , Factor de Crecimiento Transformador beta3/metabolismo , Factor de Transcripción SOX9/metabolismo , Líquido AmnióticoRESUMEN
Articular cartilage is an avascular and aneural tissue with limited capacity for regeneration. On large articular lesions, it is recommended to use regenerative medicine strategies, like autologous chondrocyte implantation. There is a concern about morphological changes that chondrocytes suffer once they have been isolated and cultured. Due to the fact that there is little evidence that compares articular cartilage chondrocytes with cultured chondrocytes, in this research we proposed to obtain chondrocytes from human articular cartilage, compare them with themselves once they have been cultured and characterize them through genetic, phenotypic and morphological analysis. Knee articular cartilage samples of 10 mm were obtained, and each sample was divided into two fragments; a portion was used to determine gene expression, and from the other portion, chondrocytes were obtained by enzymatic disaggregation, in order to be cultured and expanded in vitro. Subsequently, morphological, genetic and phenotypic characteristics were compared between in situ (articular cartilage) and cultured chondrocytes. Obtained cultured chondrocytes were rounded in shape, possessing a large nucleus with condensed chromatin and a clear cytoplasm; histological appearance was quite similar to typical chondrocyte. The expression levels of COL2A1 and COL10A1 genes were higher in cultured chondrocytes than in situ chondrocytes; moreover, the expression of COL1A1 was almost undetectable on cultured chondrocytes; likewise, COL2 and SOX9 proteins were detected by immunofluorescence. We concluded that chondrocytes derived from adult human cartilage cultured for 21 days do not tend to dedifferentiate, maintaining their capacity to produce matrix and also retaining their synthesis capacity and morphology.
Asunto(s)
Cartílago Articular/citología , Cartílago Articular/metabolismo , Condrocitos/citología , Condrocitos/metabolismo , Fenotipo , Adulto , Células Cultivadas , Colágeno Tipo II/análisis , Colágeno Tipo II/genética , Colágeno Tipo XI/genética , Técnica del Anticuerpo Fluorescente , Humanos , Inmunohistoquímica , Factor de Transcripción SOX9/análisis , Adulto JovenRESUMEN
UNLABELLED: Diseases of the genitourinary tract can lead to significant damage. Current reconstructive techniques are limited by tissue availability and compatibility. This study aims to assess if the decellularized human glans can be used as a biomaterial for penile reconstruction. MATERIALS AND METHODS: Samples of the glans matrices were descellularized. We evaluate the presence of collagen type I and III, and elastic fibers. Biocompatibility assays were performed to assess the cytotoxic and non-cytotoxic interactions between the acellular matrix and 3T3 cells. The matrices were seeded with mesenchymal stem cells and were assessed for viability and integration of these cells. Biomechanical tests in native tissue, descellularized matrix and seeded matrix were performed to characterize their biomechanical properties. RESULTS: The tissue architecture of the decellularized matrix of human glans was preserved as well as the maintenance of the biomechanical and biological properties. The analyzes of glans seeded with mesenchymal stem cells revealed the integration of these cells to the matrices, and its viability during two weeks "in vitro". CONCLUSION: The decellularization process did not alter the biological and biomechanical characteristics of the human glans. When these matrices were seeded they were able to maintain the cells integrity and vitality.
Asunto(s)
Materiales Biocompatibles , Matriz Extracelular/fisiología , Células Madre Mesenquimatosas/fisiología , Pene/citología , Ingeniería de Tejidos/métodos , Andamios del Tejido , Células 3T3/fisiología , Animales , Fenómenos Biomecánicos , Células Cultivadas , Colágeno Tipo I/análisis , Colágeno Tipo II/análisis , Humanos , Masculino , Ensayo de Materiales , Células Madre Mesenquimatosas/citología , Ratones , Ratas Wistar , Reproducibilidad de los Resultados , Factores de TiempoRESUMEN
Damage to cartilage causes a loss of type II collagen (Col-II) and glycosaminoglycans (GAG). To restore the original cartilage architecture, cell factors that stimulate Col-II and GAG production are needed. Insulin-like growth factor I (IGF-I) and transcription factor SOX9are essential for the synthesis of cartilage matrix, chondrocyte proliferation, and phenotype maintenance. We evaluated the combined effect of IGF-I and SOX9 transgene expression on Col-II and GAG production by cultured human articular chondrocytes. Transient transfection and cotransfection were performed using two mammalian expression plasmids (pCMV-SPORT6), one for each transgene. At day 9 post-transfection, the chondrocytes that were over-expressing IGF-I/SOX9 showed 2-fold increased mRNA expression of the Col-II gene, as well as a 57% increase in Col-II protein, whereas type I collagen expression (Col-I) was decreased by 59.3% compared with controls. The production of GAG by these cells increased significantly compared with the controls at day 9 (3.3- vs 1.8-times, an increase of almost 83%). Thus, IGF-I/SOX9 cotransfected chondrocytes may be useful for cell-based articular cartilage therapies.
Asunto(s)
Humanos , Condrocitos/metabolismo , Colágeno Tipo II/biosíntesis , Glicosaminoglicanos/biosíntesis , Factor I del Crecimiento Similar a la Insulina/metabolismo , Proteínas Matrilinas/biosíntesis , Factor de Transcripción SOX9/metabolismo , Transfección/métodos , Cartílago Articular/lesiones , Cartílago Articular/metabolismo , Colágeno Tipo II/análisis , Matriz Extracelular/química , Expresión Génica , Glicosaminoglicanos/análisis , Factor I del Crecimiento Similar a la Insulina/genética , Proteínas Matrilinas/genética , Cultivo Primario de Células , Reacción en Cadena en Tiempo Real de la Polimerasa , ARN Mensajero/metabolismo , Factor de Transcripción SOX9/genética , EspectrofotometríaRESUMEN
Damage to cartilage causes a loss of type II collagen (Col-II) and glycosaminoglycans (GAG). To restore the original cartilage architecture, cell factors that stimulate Col-II and GAG production are needed. Insulin-like growth factor I (IGF-I) and transcription factor SOX9are essential for the synthesis of cartilage matrix, chondrocyte proliferation, and phenotype maintenance. We evaluated the combined effect of IGF-I and SOX9 transgene expression on Col-II and GAG production by cultured human articular chondrocytes. Transient transfection and cotransfection were performed using two mammalian expression plasmids (pCMV-SPORT6), one for each transgene. At day 9 post-transfection, the chondrocytes that were over-expressing IGF-I/SOX9 showed 2-fold increased mRNA expression of the Col-II gene, as well as a 57% increase in Col-II protein, whereas type I collagen expression (Col-I) was decreased by 59.3% compared with controls. The production of GAG by these cells increased significantly compared with the controls at day 9 (3.3- vs 1.8-times, an increase of almost 83%). Thus, IGF-I/SOX9 cotransfected chondrocytes may be useful for cell-based articular cartilage therapies.
Asunto(s)
Condrocitos/metabolismo , Colágeno Tipo II/biosíntesis , Glicosaminoglicanos/biosíntesis , Factor I del Crecimiento Similar a la Insulina/metabolismo , Proteínas Matrilinas/biosíntesis , Factor de Transcripción SOX9/metabolismo , Transfección/métodos , Cartílago Articular/lesiones , Cartílago Articular/metabolismo , Colágeno Tipo II/análisis , Matriz Extracelular/química , Expresión Génica , Glicosaminoglicanos/análisis , Humanos , Factor I del Crecimiento Similar a la Insulina/genética , Proteínas Matrilinas/genética , Cultivo Primario de Células , ARN Mensajero/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , Factor de Transcripción SOX9/genética , EspectrofotometríaRESUMEN
ABSTRACT Objectives: Diseases of the genitourinary tract can lead to significant damage. Current reconstructive techniques are limited by tissue availability and compatibility. This study aims to assess if the decellularized human glans can be used as a biomaterial for penile reconstruction. Materials and Methods: Samples of the glans matrices were descellularized. We evaluate the presence of collagen type I and III, and elastic fibers. Biocompatibility assays were performed to assess the cytotoxic and non-cytotoxic interactions between the acellular matrix and 3T3 cells. The matrices were seeded with mesenchymal stem cells and were assessed for viability and integration of these cells. Biomechanical tests in native tissue, descellularized matrix and seeded matrix were performed to characterize their biomechanical properties. Results: The tissue architecture of the decellularized matrix of human glans was preserved as well as the maintenance of the biomechanical and biological properties. The analyzes of glans seeded with mesenchymal stem cells revealed the integration of these cells to the matrices, and its viability during two weeks "in vitro". Conclusion: The decellularization process did not alter the biological and biomechanical characteristics of the human glans. When these matrices were seeded they were able to maintain the cells integrity and vitality.
Asunto(s)
Animales , Humanos , Masculino , Ratones , Materiales Biocompatibles , Matriz Extracelular/fisiología , Células Madre Mesenquimatosas/fisiología , Pene/citología , Andamios del Tejido , Ingeniería de Tejidos/métodos , /fisiología , Fenómenos Biomecánicos , Células Cultivadas , Colágeno Tipo I/análisis , Colágeno Tipo II/análisis , Ensayo de Materiales , Células Madre Mesenquimatosas/citología , Ratas Wistar , Reproducibilidad de los Resultados , Factores de TiempoRESUMEN
Limitations on tissue proliferation capacity determined by telomerase/apoptosis balance have been implicated in pathogenesis of idiopathic pulmonary fibrosis. In addition, collagen V shows promise as an inductor of apoptosis. We evaluated the quantitative relationship between the telomerase/apoptosis index, collagen V synthesis, and epithelial/fibroblast replication in mice exposed to butylated hydroxytoluene (BHT) at high oxygen concentration. Two groups of mice were analyzed: 20 mice received BHT, and 10 control mice received corn oil. Telomerase expression, apoptosis, collagen I, III, and V fibers, and hydroxyproline were evaluated by immunohistochemistry, in situ detection of apoptosis, electron microscopy, immunofluorescence, and histomorphometry. Electron microscopy confirmed the presence of increased alveolar epithelial cells type 1 (AEC1) in apoptosis. Immunostaining showed increased nuclear expression of telomerase in AEC type 2 (AEC2) between normal and chronic scarring areas of usual interstitial pneumonia (UIP). Control lungs and normal areas from UIP lungs showed weak green birefringence of type I and III collagens in the alveolar wall and type V collagen in the basement membrane of alveolar capillaries. The increase in collagen V was greater than collagens I and III in scarring areas of UIP. A significant direct association was found between collagen V and AEC2 apoptosis. We concluded that telomerase, collagen V fiber density, and apoptosis evaluation in experimental UIP offers the potential to control reepithelization of alveolar septa and fibroblast proliferation. Strategies aimed at preventing high rates of collagen V synthesis, or local responses to high rates of cell apoptosis, may have a significant impact in pulmonary fibrosis.
Asunto(s)
Animales , Masculino , Apoptosis/fisiología , Colágeno Tipo V/biosíntesis , Fibrosis Pulmonar Idiopática/patología , Fibrosis Pulmonar/patología , Telomerasa/metabolismo , Hidroxitolueno Butilado , Proliferación Celular , Colágeno Tipo I/análisis , Colágeno Tipo II/análisis , Colágeno Tipo V/análisis , Modelos Animales de Enfermedad , Células Epiteliales/metabolismo , Células Epiteliales/patología , Técnica del Anticuerpo Fluorescente , Fibroblastos/metabolismo , Fibroblastos/patología , Hidroxiprolina/análisis , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Ratones Endogámicos BALB C , Microscopía Electrónica , Alveolos Pulmonares/patología , Alveolos Pulmonares/ultraestructura , Coloración y Etiquetado , Telomerasa/aislamiento & purificaciónRESUMEN
Limitations on tissue proliferation capacity determined by telomerase/apoptosis balance have been implicated in pathogenesis of idiopathic pulmonary fibrosis. In addition, collagen V shows promise as an inductor of apoptosis. We evaluated the quantitative relationship between the telomerase/apoptosis index, collagen V synthesis, and epithelial/fibroblast replication in mice exposed to butylated hydroxytoluene (BHT) at high oxygen concentration. Two groups of mice were analyzed: 20 mice received BHT, and 10 control mice received corn oil. Telomerase expression, apoptosis, collagen I, III, and V fibers, and hydroxyproline were evaluated by immunohistochemistry, in situ detection of apoptosis, electron microscopy, immunofluorescence, and histomorphometry. Electron microscopy confirmed the presence of increased alveolar epithelial cells type 1 (AEC1) in apoptosis. Immunostaining showed increased nuclear expression of telomerase in AEC type 2 (AEC2) between normal and chronic scarring areas of usual interstitial pneumonia (UIP). Control lungs and normal areas from UIP lungs showed weak green birefringence of type I and III collagens in the alveolar wall and type V collagen in the basement membrane of alveolar capillaries. The increase in collagen V was greater than collagens I and III in scarring areas of UIP. A significant direct association was found between collagen V and AEC2 apoptosis. We concluded that telomerase, collagen V fiber density, and apoptosis evaluation in experimental UIP offers the potential to control reepithelization of alveolar septa and fibroblast proliferation. Strategies aimed at preventing high rates of collagen V synthesis, or local responses to high rates of cell apoptosis, may have a significant impact in pulmonary fibrosis.
Asunto(s)
Apoptosis/fisiología , Colágeno Tipo V/biosíntesis , Fibrosis Pulmonar Idiopática/patología , Fibrosis Pulmonar/patología , Telomerasa/metabolismo , Animales , Hidroxitolueno Butilado , Proliferación Celular , Colágeno Tipo I/análisis , Colágeno Tipo II/análisis , Colágeno Tipo V/análisis , Modelos Animales de Enfermedad , Células Epiteliales/metabolismo , Células Epiteliales/patología , Fibroblastos/metabolismo , Fibroblastos/patología , Técnica del Anticuerpo Fluorescente , Hidroxiprolina/análisis , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Masculino , Ratones Endogámicos BALB C , Microscopía Electrónica , Alveolos Pulmonares/patología , Alveolos Pulmonares/ultraestructura , Coloración y Etiquetado , Telomerasa/aislamiento & purificaciónRESUMEN
PURPOSE: Articular Cartilage has limited potential for self-repair and tissue engineering approaches attempt to repair articular cartilage by scaffolds. We hypothesized that the combined hydroxyapatite and zirconia stabilized yttria would enhance the quality of cartilage healing. METHODS: In ten New Zealand white rabbits bilateral full-thickness osteochondral defect, 4 mm in diameter and 3 mm depth, was created on the articular cartilage of the patellar groove of the distal femur. In group I the scaffold was implanted into the right stifle and the same defect was created in the left stifle without any transplant (group II). Specimens were harvested at 12 weeks after implantation, examined histologically for morphologic features, and stained immunohistochemically for type-II collagen. RESULTS: In group I the defect was filled with a white translucent cartilage tissue In contrast, the defects in the group II remained almost empty. In the group I, the defects were mostly filled with hyaline-like cartilage evidenced but defects in group II were filled with fibrous tissue with surface irregularities. Positive immunohistochemical staining of type-II collagen was observed in group I and it was absent in the control group. CONCLUSION: The hydroxyapatite/yttria stabilized zirconia scaffold would be an effective scaffold for cartilage tissue engineering.
Asunto(s)
Materiales Biocompatibles/uso terapéutico , Cartílago Articular/lesiones , Durapatita/uso terapéutico , Nanoestructuras/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Itrio/uso terapéutico , Circonio/uso terapéutico , Animales , Colágeno Tipo II/análisis , Masculino , Ensayo de Materiales , Conejos , Regeneración/efectos de los fármacos , Reproducibilidad de los Resultados , Propiedades de Superficie , Factores de Tiempo , Resultado del TratamientoRESUMEN
PURPOSE: Articular Cartilage has limited potential for self-repair and tissue engineering approaches attempt to repair articular cartilage by scaffolds. We hypothesized that the combined hydroxyapatite and zirconia stabilized yttria would enhance the quality of cartilage healing. METHODS: In ten New Zealand white rabbits bilateral full-thickness osteochondral defect, 4 mm in diameter and 3 mm depth, was created on the articular cartilage of the patellar groove of the distal femur. In group I the scaffold was implanted into the right stifle and the same defect was created in the left stifle without any transplant (group II). Specimens were harvested at 12 weeks after implantation, examined histologically for morphologic features, and stained immunohistochemically for type-II collagen. RESULTS: In group I the defect was filled with a white translucent cartilage tissue In contrast, the defects in the group II remained almost empty. In the group I, the defects were mostly filled with hyaline-like cartilage evidenced but defects in group II were filled with fibrous tissue with surface irregularities. Positive immunohistochemical staining of type-II collagen was observed in group I and it was absent in the control group. CONCLUSION: The hydroxyapatite/yttria stabilized zirconia scaffold would be an effective scaffold for cartilage tissue engineering.
Asunto(s)
Animales , Masculino , Conejos , Materiales Biocompatibles/uso terapéutico , Cartílago Articular/lesiones , Durapatita/uso terapéutico , Nanoestructuras/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Itrio/uso terapéutico , Circonio/uso terapéutico , Colágeno Tipo II/análisis , Ensayo de Materiales , Reproducibilidad de los Resultados , Regeneración/efectos de los fármacos , Propiedades de Superficie , Factores de Tiempo , Resultado del TratamientoRESUMEN
Las enfermedades autoimunitarias constituyen hoy en día un problema de salud de relevancia, especialmenteporque son enfermedades crónicas severas que afectan considerablemente la calidad de vida de los pacientes yademás porque en la mayoría de los casos el tratamiento es solamente paliativo e insatisfactorio pues no modifica la evolución de la enfermedad. Un ejemplo bien conocido de este tipo de enfermedad es el de la ArtritisReumatoidea. En este sentido interesantes estudios handemostrado que la inducción de la tolerancia inmunológica por vía oral es efectiva en enfermedades autoinmunes humanas, constituyendo una alternativaventajosa, simple y barata de tratamiento. Dos mecanismos parecen estar involucrados: interacción, anivel de mucosas, del antígeno con células linfocitarias reguladoras (LTreg) que ejercerían un efecto supresorde la respuesta inmunitaria específica contra el antígeno ingerido11, o interacción de células dendríticas concélulas epiteliales que tiene deficiencia en moléculas coestimulatorias (CD80 y CD86), lo que conduciría a inducción de tolerancia.
Asunto(s)
Artritis Reumatoide/inmunología , Artritis/patología , Colágeno Tipo II/análisisRESUMEN
OBJECTIVE: To evaluate the effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on rat articular chondrocyte (AC) with respect to DNA synthesis, collagen type II and proteoglycan (PG) synthesis and expression, and cAMP production; to examine these cells for the presence of GM-CSF-specific binding sites; and to study their regulation by growth factors and cytokines. METHODS: First passage monolayers of rat AC were incubated with various concentrations of recombinant human GM-CSF, and then [3H]-thymidine, [3H]-proline, and [35S]SO4 incorporation and cAMP production were measured. The density of GM-CSF-specific binding sites, the effects of growth factors and cytokines on receptor density, and the activation of certain post-receptor signaling pathways were also examined by labeling the cell monolayers with [125I]-GM-CSF. RESULTS: GM-CSF (6-100 U/ml) inhibited (30%) [3H]-thymidine incorporation into DNA, and, in contrast, stimulated up to 3.6- and 2-fold [35S]SO4 and [3H]-proline incorporation into glycosaminoglycan side chains and collagen molecules, respectively. GM-CSF also increased aggrecan and type II collagen (Coll II) transcripts by 2- to 3-fold, respectively. These effects were associated with a concentration-dependent increase in cAMP production. A single class of high affinity (Kd = 98 pM; Bmax = 7.08 pM/microg DNA) binding sites of about 220 kDa were found. The [125I]-GM-CSF binding to the cells was slightly increased with phorbol 12-myristate 13-acetate (PMA), insulin-like growth factor-I, platelet derived growth factor, basic fibroblast growth factor, and tumor necrosis factor-alpha, and decreased with pertussis toxin, cholera toxin, and interleukin-1beta. CONCLUSION: These results suggest that GM-CSF may play a role in the regulation of chondrocyte metabolism as an anabolic agent and may stimulate cartilage healing under pathological conditions.